close

Introducing LANLUMA

Sinclair introduces a new bio-stimulating dermal filler for body-contouring



According to a survey, a third of UK adults have felt anxious because of concerns about their body image. Body contouring treatments were the second most requested treatments over the last year, with a 450% year-on year growth. There is also a growing inclination towards non-invasive cosmetic treatments and filler treatments, which increased by 11.7%, compared with a decrease in surgical pro-cedures by 0.6%.

Product range

It is against this backdrop that a new bio-stimulating dermal filler for the body has been launched by Sinclair Pharma. There are two products in the Lanluma range; V for the hands and face, and X for larger areas of the body. Lanluma has been specifically formulated to reshape and contour large areas of the body and can be used to treat the upper arms, hips, thighs, hands, décolletage and buttocks. It can also be used to reduce the signs of cellulite and wrinkles. Lanluma can also be used to add volume to the face to compensate for age-related tissue and bone loss which causes lines and sagging.

Composition
Lanluma is made from Poly-l-lactic Acid (PLLA) which has been used in medical products for 30 years and has a strong safety record. The formulation induces collagenasis and fibroblast proliferation by stimulating the body’s inflammatory response. The bio-stimulation helps to restore the skin’s inner structure and shape. The injected filler is absorbed by the body, and then over time the new reshaped appearance emerges. This means the results are not instant, but when they become apparent, they look convincing and realistic.
This taps into the zeitgeist for a more natural appearance—and comes hot on the heels of the findings of research which showed that 41% of people considering cosmetic treatments stated that their top concern was having an unnatural appearance.

Treatment
Depending on the size of the area to be remedied, two to four treatments are performed four to six weeks apart contingent on the results from the previous session. Patients are then asked to massage the area post-treatment to bring about the best results. As the new treatment brings about collagenesis, the results last for more than two years.

Usage
Lanluma is classified as a class III medical device and is easy to store and easy to use in clinic. The injectable PLLA Powder is a dry powder reconstituted with the addition of sterile water, and can be used in as little as ten minutes after dilution.
The ideal treatment provider will be an experienced injector with a high level of PLLA expertise who is keen to perform body procedures.

For further information see lanluma.com


References

1. Mental Health Foundation, 2019
2. Aesthetics Trends Research, Real Self, 2019
3. International Society of Aesthetic Plastic Surgery,2018
4. AAFPRS, 2019

Recommended
© Wigmore Medical is a registered pharmacy: no. 9012271